[1]Zhou Q,Zhang W,Xu H,et al.Risk factors for preterm premature rupture of membranes in Chinese women from urban cities[J].Int J Gynaecol Obstet ,2014,127(3):254-259. [2]刘惠琴.胎膜早破的病因研究进展[J].内蒙古医学杂志,2015,47(7):820-822. [3]Tigga M,Malik S.Comparative analysis of four biomarkers in diagnosing premature rupture of membranes and their correlation with onset of labour[J].Biochem Biophys Res Commun, 2015,59(2):1070-1075. [4]孙素梅,李守忠.胰岛素样生长因子结合蛋白-1诊断胎膜早破的临床价值[J].实用临床医学,2016,17(2):43-45. [5]耿炫,高玉民,刘菲菲.胎膜早破的病因及其发病机制的研究进展[J].实用医药杂志,2012,29(8):745-747. [6]贺玲,张运平.胎膜早破生化诊断标志物的研究进展[J].中国妇幼卫生杂志,2014,5(1):77-78. [7]Eskicioglu F,Gur EB.Diagnostic modalities in premature rupture of membranes[J].Int J Women’s Health Reprod Sci,2015,3(2):89-92. [8]Puntachai P,Wanapirak C,Sirichotiyakul S,et al.Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels [J].Arch Gynecol Obstet ,2015,292(1):81-85. [9]赵金珩.妊娠中晚期母血清甲胎蛋白水平与胎膜早破相关性的研究进展[J].中国煤炭工业医学杂志,2011,14(2):301-303. [10]Knapik D,Olejek A.Analysis of cervicovaginal fluid in the diagnosis of premature rupture of membranes [J].Ginekol Pol,2011,82(1):50-55. [11]李翠梅.阴道液HCG的定性测定在胎膜早破诊断中的应用价值[J].临床医学工程,2015,22(7):879-881. [12]Bahasadri S,Kashanian M,Khalili S.Evaluation of vaginal fluid β-human chorionic gonadotrophin for the diagnosis of preterm premature rupture of membranes[J].J Obstet Gynaecol Res , 2013,39(4):777-782. [13]郭莹.胰岛素样生长因子结合蛋白-1检测胎膜早破及预测早产临床价值[J].临床合理用药杂志,2016,9(32):136-137. [14]Abdelazim IA.Insulin-like growth factor binding protein-1 (Actim PROM test ) for detection of premature rupture of fetal membranes[J].J Obstet Gynaecol Res,2014,40(4):961-967. [15]王琳.胰岛素生长因子结合蛋白-1联合HCG在胎膜早破诊断中的价值[J].海南医学院学报,2012,18(11):1637-1639. [16]Abdelazim I A,Al-Sherbeeny M M,Ibrahim M E M,et al.Insulin-like Growth Factor Binding Protein-1/alpha-fetoprotein versus Placental alpha microglobulin-1 for diagnosis of premature fetal membranes rupture[J].Acta Med Int,2016,3(1):69-73. [17]金慕华,谢建渝.3种快速检测方法联合检测在诊断胎膜早破中的临床意义[J].检验医学与临床,2014,11(5):678-679.